Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus cortisone for gluteal tendinopathy
ACTRN12613000677707Phase 3Completed
- Sponsor
- Dr Jane Fitzpatrick
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gluteal tendinopathy (GTPS) comparing Platelet-rich plasma with Celestone Chronodose (2 arms). Primary endpoint: Change from baseline in Modified Harris Hip Score. Started May 2013; status: completed.
02
Drugs
platelet-rich plasmabetamethasone sodium
03
Conditions
gluteal tendinopathy (GTPS)
Beyond the preview
Go deeper on ACTRN12613000677707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000677707.